Alivus Life Sciences Limited — Updates, 21-03-2026: General Updates
21-03-2026 | 12:52 pm
21-03-2026 | 12:52 pm
Alivus Life Sciences received an Income Tax demand of Rs. 2.61 Cr for FY2022-23 due to disallowed expenses. The company states there is no material financial or operational impact and plans to evaluate an appeal.
No comments yet. Be the first to comment!
